The Importance of Absorption, Distribution, and Excretion (ADME) Testing in Supporting Drug Development
Even if a candidate substance has excellent pharmacological activity, it cannot become a drug if it is not properly absorbed, distributed, metabolized, and excreted in the body. The preclinical pharmacokinetic studies (ADME evaluation) introduced in this article can be said to be an important process for ensuring efficacy and safety.
Absorption, distribution, metabolism, and excretion processes
The acronym ADME, derived from the initial letters of "Absorption," "Distribution," "Metabolism," and "Excretion," refers to the movement of drugs within the body. Each of these processes is explained below.
Absorption
"Absorption" of a drug refers toThe process by which a substance moves from the administration site (e.g., the gastrointestinal tract) into the bloodstream.In non-clinical absorption studies,The objective is to confirm how quickly and in what quantity the drugs enter the bloodstream.This is why it is crucial for subsequent study planning to accurately assess absorption rate and blood concentration trends, as insufficient absorption will prevent the drug from taking effect.
Distribution
distributionThe process by which a drug that has entered the bloodstream is transported by blood flow to tissues and organs throughout the bodyrefers to. This test is used to determine the efficacy of a drugConfirm that the drug has sufficiently reached the target organ.in addition toHas it accumulated excessively in any specific organ?The objectives include investigating points such as: It is essential to quantitatively and visually grasp the distribution status throughout the body to ensure that it does not accumulate in unintended organs.
Metabolism
Metabolism isThe process by which drugs change their structure within the bodyprocessed. Primarily through the action of metabolic enzymes present in the liver and other organs, the original drug is converted into another substance (metabolite), making it easier to excrete. Here,Investigate the inhibition and induction of metabolic enzymes (CYP, etc.).This is extremely important. This process plays a role in predicting the risk of "drug interactions" that can occur when used with other medications and ensuring safety.
Excretion
"Excretion" is the process by which drugs or their metabolites are ultimately eliminated from the body through the kidneys (urine) or liver (bile). In this study,Identify the route and speed at which it is eliminated from the body.The purpose is to understand whether it is rapidly excreted from the body or remains for a long time, which will be important information for setting appropriate dosages and administration intervals in clinical practice.
Key kinetic parameters from the test
Here are the key pharmacokinetic parameters obtained from the study. In this way, the data obtained through the study will form the basis for the dosing plan in subsequent clinical trials.
| Bioavailability (F) |
The proportion of the dose that reached systemic circulation unchanged. This indicates the oral bioavailability. |
| Volume of Distribution (Vd) |
The ratio of the total amount of drug in the body to its blood concentration. A larger value indicates that the drug is not retained in the blood but is widely distributed into tissues. |
| Clearance (CL) |
The volume of blood from which the drug is completely removed per unit of time. A comprehensive indicator of the ability to eliminate drugs through metabolism and excretion. |
| Half-life (T½) |
The time it takes for the blood concentration to become half. A guideline for determining the dosing interval (once a day, twice a day, etc.). |
Advantages of Utilizing CROs for Dynamic Testing Optimization
Performing dynamic testing requires advanced analytical techniques for evaluation. This explanation covers the benefits of utilizing a specialized CRO for this purpose.
Balancing high-quality analysis with speed
For non-clinical pharmacokinetic evaluation, in order to accurately measure trace amounts of drug concentrations in biological samples,High-sensitivity analytical instruments such as LC-MS/MS, and the skilled techniques to operate themSpecialized CROs can be utilized to significantly reduce the time and cost of establishing an in-house analytics function from scratch, enabling the acquisition of rapid and reliable data, thereby accelerating development speed.
Comprehensive support that complies with guidelines
When conducting non-clinical studies, international standards such as ICHIt is necessary to implement according to various guidelines.There are benefits to utilizing an experienced CRO, such as receiving comprehensive support that considers the latest regulatory requirements, rather than just outsourcing analysis. Furthermore, CRO support can be highly effective in advancing studies, including consulting on study design and selecting appropriate animal species for the target drug.
Summary
ADME studies in non-clinical settings are the lifeline for determining whether a lead compound possesses "drug-likeness." During development,By accurately understanding drug behavior in the body at an early stage, the risk of dropout in subsequent trials can be reduced.Yes. Furthermore, because it is a test that requires advanced expertise, selecting and utilizing a CRO that meets the needs of your company is key to project success.
Japanese
